CTIM-40. IMMUNE PROFILING OF GBM TUMOR TISSUES COLLECTED LONGITUDINALLY FROM PATIENTS TREATED WITH AN ONCOLYTIC VIRUS
Sreyashi Basu(The University of Texas MD Anderson Cancer Center), Padmanee Sharma(The University of Texas MD Anderson Cancer Center), Alexander Ling(Centre for Quantum Technologies), Betty Y.S. Kim(The University of Texas MD Anderson Cancer Center), Kenny Yu(Memorial Sloan Kettering Cancer Center), Jason T. Huse(The University of Texas MD Anderson Cancer Center), Vinay K. Puduvalli(The University of Texas MD Anderson Cancer Center), Sangeeta Goswami(The University of Texas MD Anderson Cancer Center), Sonali Jindal(The University of Texas MD Anderson Cancer Center), David A. Reardon(Dana-Farber Cancer Institute), Viviane Tabar(Memorial Sloan Kettering Cancer Center), Frederick Lang(Houston Medical Center), Wen Jiang(The University of Texas MD Anderson Cancer Center), Jian Hu(Houston Medical Center), Antonio Chiocca(Harvard University), G B M TeamLab(Breakthrough), Forest M. White(Center for Cancer Research), Marla J. Polk(Houston Medical Center), Keith L. Ligon(Brigham and Women's Hospital)
Cited by 0
Related Papers
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma
|Cell|2016|2.4k
Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial
|The Lancet Oncology|2017|1.8k
Phosphoproteome analysis by mass spectrometry and its application to Saccharomyces cerevisiae
|Nature Biotechnology|2002|1.6k